CSGP vs KAPA · P/E 484, rev $1.82B vs $18.8M cap
CoStar Group Inc (CSGP) versus Kairos Pharma, Ltd. (KAPA) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
KAPA does not have a complete income-statement cache yet.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. KAPA currently screens at market cap $18.8M.
Not investment advice. Open the CSGP and KAPA stock pages for the full models.
Not investment advice.